Methylphenidate and attributions in boys with attention-deficit hyperactivity disorder

Area of Science:

• Child and Adolescent Psychiatry
• Behavioral Psychology
• Neurodevelopmental Disorders

Background:

• Attention-deficit hyperactivity disorder (ADHD) affects behavior and academic performance.
• Understanding attributions in ADHD is crucial for effective interventions.
• Methylphenidate is a common medication for managing ADHD symptoms.

Purpose of the Study:

• To investigate how ADHD boys attribute behavioral improvements during methylphenidate treatment.
• To examine the impact of medication versus effort attributions on perceived treatment outcomes.
• To compare attributional patterns for success and failure in ADHD boys.

Main Methods:

• Two experiments involving boys diagnosed with ADHD in a day-treatment program.
• Double-blind, placebo-controlled medication assessments with methylphenidate.
• Daily questionnaires assessing attributions for behavior and performance outcomes.

Main Results:

• Objective measures showed behavioral improvement with methylphenidate.
• Boys attributed success to effort or ability, and failure to external factors like medication or counselors.
• No significant difference was found in a no-pill versus placebo condition, but placebo-methylphenidate comparisons replicated findings.

Conclusions:

• ADHD boys exhibit a self-enhancing attributional bias, attributing success to internal factors and failure to external ones.
• This bias influences how they perceive the efficacy of ADHD medication.
• Further research should explore interventions to modify these attributional patterns for improved treatment adherence and outcomes.